![PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/61dfda9a1512d58d66ac672569d4f3193a851ba9/7-Figure5-1.png)
PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar
![PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/61dfda9a1512d58d66ac672569d4f3193a851ba9/8-Figure7-1.png)
PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar
![Polycomb group protein Bmi1 is required for the neuronal differentiation of mouse induced pluripotent stem cells Polycomb group protein Bmi1 is required for the neuronal differentiation of mouse induced pluripotent stem cells](https://www.spandidos-publications.com/article_images/etm/21/6/etm-21-06-10051-g03.jpg)
Polycomb group protein Bmi1 is required for the neuronal differentiation of mouse induced pluripotent stem cells
![Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology](https://www.frontiersin.org/files/Articles/470207/fphar-10-01199-HTML-r1/image_m/fphar-10-01199-g004.jpg)
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
![Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target - Shields - 2021 - Molecular Oncology - Wiley Online Library Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target - Shields - 2021 - Molecular Oncology - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/5474751d-5815-4869-94a0-f45a69068ebf/mol212914-fig-0003-m.jpg)
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target - Shields - 2021 - Molecular Oncology - Wiley Online Library
![PTC-209 reduces BMI-1 levels, PRC1 activity, and inhibits cell growth... | Download Scientific Diagram PTC-209 reduces BMI-1 levels, PRC1 activity, and inhibits cell growth... | Download Scientific Diagram](https://www.researchgate.net/profile/Shiva-Senthil-Kumar/publication/317022344/figure/fig2/AS:614124455206928@1523430088790/PTC-209-reduces-BMI-1-levels-PRC1-activity-and-inhibits-cell-growth-of-DIPG.png)
PTC-209 reduces BMI-1 levels, PRC1 activity, and inhibits cell growth... | Download Scientific Diagram
![PTC209, a Specific Inhibitor of BMI1, Promotes Cell Cycle Arrest and Apoptosis in Cervical Cancer Cell Lines | Anticancer Research PTC209, a Specific Inhibitor of BMI1, Promotes Cell Cycle Arrest and Apoptosis in Cervical Cancer Cell Lines | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/1/133/F1.large.jpg)
PTC209, a Specific Inhibitor of BMI1, Promotes Cell Cycle Arrest and Apoptosis in Cervical Cancer Cell Lines | Anticancer Research
![PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/61dfda9a1512d58d66ac672569d4f3193a851ba9/4-Figure2-1.png)
PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar
![PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/61dfda9a1512d58d66ac672569d4f3193a851ba9/2-Figure1-1.png)
PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar
![Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology](https://www.frontiersin.org/files/Articles/470207/fphar-10-01199-HTML-r1/image_m/fphar-10-01199-g002.jpg)
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
![Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology](https://www.frontiersin.org/files/Articles/470207/fphar-10-01199-HTML-r1/image_m/fphar-10-01199-g007.jpg)
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
![The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells | Blood Cancer Journal The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbcj.2017.8/MediaObjects/41408_2017_Article_BFbcj20178_Fig1_HTML.jpg)
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells | Blood Cancer Journal
![Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes | Scientific Reports Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-63992-8/MediaObjects/41598_2020_63992_Fig2_HTML.png)
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes | Scientific Reports
![Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology](https://www.frontiersin.org/files/Articles/470207/fphar-10-01199-HTML-r1/image_m/fphar-10-01199-g003.jpg)
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
![BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse - ScienceDirect BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1934590920302897-fx1.jpg)
BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse - ScienceDirect
![BMI-1 downregulation by PTC-209 affects stemness properties of DIPG.... | Download Scientific Diagram BMI-1 downregulation by PTC-209 affects stemness properties of DIPG.... | Download Scientific Diagram](https://www.researchgate.net/profile/Shiva-Senthil-Kumar/publication/317022344/figure/fig6/AS:614124459421703@1523430089674/BMI-1-downregulation-by-PTC-209-affects-stemness-properties-of-DIPG-A-GFAP-and-Nestin.png)
BMI-1 downregulation by PTC-209 affects stemness properties of DIPG.... | Download Scientific Diagram
![Cancers | Free Full-Text | BMI1-Mediated Pemetrexed Resistance in Non-Small Cell Lung Cancer Cells Is Associated with Increased SP1 Activation and Cancer Stemness | HTML Cancers | Free Full-Text | BMI1-Mediated Pemetrexed Resistance in Non-Small Cell Lung Cancer Cells Is Associated with Increased SP1 Activation and Cancer Stemness | HTML](https://www.mdpi.com/cancers/cancers-12-02069/article_deploy/html/images/cancers-12-02069-g008.png)
Cancers | Free Full-Text | BMI1-Mediated Pemetrexed Resistance in Non-Small Cell Lung Cancer Cells Is Associated with Increased SP1 Activation and Cancer Stemness | HTML
![Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor PTC‐209 in acute myeloid leukemia: Implications for leukemia therapy - Nishida - 2015 - Cancer Science - Wiley Online Library Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor PTC‐209 in acute myeloid leukemia: Implications for leukemia therapy - Nishida - 2015 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/bf97b9b0-7451-4b9b-83b7-c86e5433395a/cas12833-fig-0006-m.jpg)
Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor PTC‐209 in acute myeloid leukemia: Implications for leukemia therapy - Nishida - 2015 - Cancer Science - Wiley Online Library
![Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology](https://www.frontiersin.org/files/Articles/470207/fphar-10-01199-HTML-r1/image_m/fphar-10-01199-g005.jpg)
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
![Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment | Journal of Hematology & Oncology | Full Text Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-016-0247-4/MediaObjects/13045_2016_247_Fig4_HTML.gif)
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment | Journal of Hematology & Oncology | Full Text
![Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma | Cancer Cell International | Full Text Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-017-0481-z/MediaObjects/12935_2017_481_Fig5_HTML.gif)
Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma | Cancer Cell International | Full Text
![IJMS | Free Full-Text | Inhibition of BMI-1 Induces Apoptosis through Downregulation of DUB3-Mediated Mcl-1 Stabilization | HTML IJMS | Free Full-Text | Inhibition of BMI-1 Induces Apoptosis through Downregulation of DUB3-Mediated Mcl-1 Stabilization | HTML](https://www.mdpi.com/ijms/ijms-22-10107/article_deploy/html/images/ijms-22-10107-g004.png)